You are here

Article Text

Article menu
Download PDFPDF
Letters
Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis
  1. A Jamnitski1,
  2. I M Visman1,
  3. M J L Peters2,
  4. M Boers1,2,
  5. B A C Dijkmans1,2,
  6. M T Nurmohamed1,2
  1. 1Jan van Breemen Institute, Amsterdam, The Netherlands
  2. 2VU University Medical Centre, Amsterdam, The Netherlands
  1. Correspondence to Dr M T Nurmohamed, Department of Rheumatology, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands; m.nurmohamed{at}janvanbreemen.nl

https://doi.org/10.1136/ard.2010.136499

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The increased risk for cardiovascular disease (CVD) in rheumatoid arthritis (RA) is well known and inflammation appears to play a pivotal aetiological role. There is now substantial interest in whether or not psoriatic arthritis (PsA) is also associated with an enhanced cardiovascular (CV) risk. However, data on CVD in PsA is limited.1,–,3 The aim of this comparative study was to determine the prevalence of non-fatal CVD in patients with PsA compared with patients with RA and to investigate the risk factors of CVD in PsA.

    In 2008 a CV questionnaire was sent to all 753 patients with PsA aged 50–75 years registered at our centre.4 As a comparator group, data from 353 randomly selected patients with RA aged 50–75 years (the CARdiovascular research and RhEumatoid arthritis study) were …

    View Full Text

    Footnotes

    • Funding This study was financed by the Clinical Research Bureau of the Jan van Breemen Institute. The study sponsors had no involvement in the study design or in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.

    • Competing interests None.

    • Ethics approval This study was conducted with the approval of the medical ethics committee of Slotervaart ziekenhuis, Jan van Breemen Institute en Boven ij ziekenhuis.

    • Provenance and peer review Not commissioned; externally peer reviewed.